Ellen Lubman

Ellen Lubman is a highly accomplished business professional with a strong background in the biotech industry. She obtained her Bachelor of Arts in Biology at Rutgers University and went on to receive her Master of Business Administration in Management from Stanford University Graduate School of Business. With over a decade of experience in strategic business development, clinical development, and corporate management, Lubman has held various executive positions in multiple biotech organizations. Before joining Werewolf Therapeutics as Chief Business Officer, Lubman served on the Board of Directors for Field Trip Health, and as a Strategic Advisor for Tmrw Life Sciences. Previously, she was Vice President for both Allergan and Forest Laboratories, where she led strategy and innovation. Lubman also served as Senior Vice President for Corporate Development at Kadmon Holdings, Inc, and in Mergers and Acquisitions Lead at Bristol-Myers Squibb. She began her career as a Biotech Equity Research Analyst at Robertson Stephens, and a Biotech and Genomics Educational Conference Developer at the Institute for International Research. Lubman's expertise in business management, product and clinical development, and biotech entrepreneurship make her an asset to any organization.